Description: The ICAN® mission is to assist and empower late-stage cancer patients worldwide with cutting-edge information regarding anticancer drugs in clinical trials as well as physician referrals at the patient’s request based on the patient’s reported medical situation. ICAN® takes the position that there are key decision points in the battle for life and with the best available information, the cancer patient will be well-armed for the road ahead.
cancer (3276) clinical trials (383) cancer treatment (254) patient advocacy (41) stage iv cancer (5) stage 4 cancer (5)
"Patients with EGFR exon 20 insertion have a very promising drug pipeline in addition to 2 critically important drug approvals. Few rare mutation groups see this so early on... " Read more
Donate to our major fundraiser honoring Exon 20 Group Founder Kevin Hanlon, supporting our research and advocacy projects! More info here: https://askican.ejoinme.org/fistbump
ICAN ® is a 501(c)(3) patient advocacy and research advocacy organization with a small staff of professional advocates assisted by hundreds volunteers worldwide. With our volunteer leadership representing 17 different time zones, we literally work around the clock, focusing on our Personalized Medicine Cancer Case Navigation Programs, health information technology issues, legislative initiatives, and research projects.
Exon 20 Group Home
PDL1 Amplifieds Home
LCS-test site only
ICAN® International Cancer Advocacy Network
ICAN® International Cancer Advocacy Network
ICAN® International Cancer Advocacy Network
ICAN® International Cancer Advocacy Network